FDA Identifies Harm Reported from Sudden Discontinuation of Opioid Pain Medicines and Requires Labe
Updated: Nov 22, 2022
April 9, 2019
These changes will provide expanded guidance to health care professionals on how to safely decrease the dose in patients who are physically dependent on opioid pain medicines when the dose is to be decreased or the medicine is to be discontinued.